{{Rsnum
|rsid=9551963
|Gene=ALOX5AP
|Chromosome=13
|position=30758410
|Orientation=plus
|GMAF=0.4692
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ALOX5AP
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 26.7 | 40.0 | 33.3
| HCB | 41.9 | 48.8 | 9.3
| JPT | 42.5 | 52.5 | 5.0
| YRI | 19.7 | 57.4 | 23.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 41.9 | 48.8 | 9.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs9551963]], also known as SG13S32, is an [[ALOX5AP]] gene SNP that has been defined as part of a haplotype potentially associated with risk for [[myocardial infarction]] or ischemic [[stroke]]. Details of this haplotype and several related studies are on the [[ALOX5AP]] page.

{{PMID|19130089|OA=1
}} Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.

{{PMID|19361804}} 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia.

{{PMID|19751821|OA=1
}} Oxidative risk for atherothrombotic cardiovascular disease.

{{PMID|20067482|OA=1
}} The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos.

{{PMID|20810156|OA=1
}} ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.

{{PMID Auto
|PMID=24368493
|Title=Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese
}}

{{PMID Auto
|PMID=24485247
|Title=Ischemic stroke risk in a southeastern Chinese population: Insights from 5-lipoxygenase activating protein and phosphodiesterase 4D single-nucleotide polymorphisms
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}